NeuroBio is an emerging biopharmaceutical company focused on the research, development and commercialization of new marine based omega 3 phospholipid therapies for use in the human neurological field, including conditions, abnormalities and/or diseases related to cognitive functions such as attention, memory, concentration and learning and the management of neurological and neurodevelopmental disorders from prevention to treatment. NeuroBio is currently in the early stages of developing novel active pharmaceutical ingredients into commercial products for the medical food, the over the counter and the prescription drug markets. Particular focus is being given to attention-deficit hyperactivity disorder, cognitive functions, including memory and concentration, along with mood disorders, such as anxiety and depression.
Neptune Technologies & Bioressources Inc (Neptune) (Public, CVE:NTB) is a Canada-based company. The Company extracts, scientifically validates, and markets natural health products from marine biomasses and provides the krill oil accepted as a new dietary ingredient (NDI) by the United States Food and Drug Administration.
The products of the Company are Neptune Krill Aquatein (NKA) and Neptune Krill Oil (NKO). The Company is engaged in the commercialization of its products in North America, Europe, Asia and Australia.